Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 1-10 of 45

Page
per page
  1. AKT inhibitor VIII
    A3149 AKT inhibitor VIII
     2 Citation
    Target: Akt
    Summary: Allosteric Akt kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
  2. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  3. GM 6001
    A4050 GM 6001
     2 Citation
    Target: MMP
    Summary: Broad spectrum MMP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL
  4. SCH 527123
    A3802 SCH 527123
     5 Citation
    Target: CXCR
    Summary: CXCR1 and CXCR2 receptors antagonist
  5. Dorsomorphin (Compound C)
    B3252 Dorsomorphin (Compound C)
     5 Citation
    Target: AMPK
    Summary: AMPK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.49 mg/mL
  6. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP-competitive FAK inhibitor, reversible
      ≥25.35 mg/mL
  7. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  8. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  9. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    Target: CETP
    Summary: RhCETP/mutant CETP(C13S) inhibitor
      ≥31.9 mg/mL
  10. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL

Items 1-10 of 45

Page
per page